Related Experiment Video

Updated: May 27, 2026

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography
07:11

Morphological and Functional Assessment of the Right Ventricle Using 3D Echocardiography

Published on: October 28, 2020

Management of left ventricular outflow obstruction due to hypertrophic cardiomyopathy. Role of multimodality

M Luckie1, R S Khattar

  • 1Manchester Heart Center, Manchester Royal Infirmary, Manchester, UK.

Minerva Cardioangiologica
|December 3, 2011
PubMed

Insights

Hypertrophic cardiomyopathy can cause left ventricular outflow obstruction. Echocardiography is vital for diagnosing this condition, assessing obstruction, and guiding management, including alcohol septal ablation.

Area of Science:

  • Cardiology
  • Medical Imaging

Background:

  • Hypertrophic cardiomyopathy presents with diverse clinical features.
  • Left ventricular outflow obstruction is a significant complication in some patients.
  • Management strategies exist for left ventricular outflow obstruction.

Purpose of the Study:

  • To outline the role of echocardiography in assessing and managing left ventricular outflow obstruction in hypertrophic cardiomyopathy.
  • To highlight echocardiography's importance in selecting and monitoring therapy, particularly alcohol septal ablation.

Main Methods:

  • Echocardiography for diagnosis of hypertrophic cardiomyopathy.
  • Echocardiography for assessment of left ventricular outflow obstruction.
  • Echocardiography for guiding therapy selection and monitoring.

Main Results:

  • Echocardiography is crucial for diagnosing hypertrophic cardiomyopathy.
  • Echocardiography effectively assesses left ventricular outflow obstruction.
  • Echocardiography guides therapy selection, intraoperative monitoring, and follow-up for alcohol septal ablation.

Conclusions:

  • Echocardiography is indispensable in managing left ventricular outflow obstruction in hypertrophic cardiomyopathy.
  • The modality plays a key role in patient selection and monitoring for interventions like alcohol septal ablation.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular tachycardia.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...